Nature Biotechnology, Published online: 10 July 2024; doi: 10.1038/s41587-024-02321-0Biotechs are gearingup CAR-T cells to damage B cells — not to reward blood cancers, however to take on numerous sclerosis and a raft of autoimmune conditions…
Read More.
